ALLIANCE FOR CANCER GENE THERAPY INC
Balance Sheet
Fiscal Year Start:
May 1
Assets in 2025 (Year End)
$15,733,028
Investments
78%
Cash & Equivalents
21%
Receivables (Non-Related)
1%
Prepaid Expenses
<1%
Related-Party Receivables
0%
Inventories
0%
Property, Plant, & Equipment (net)
0%
Other Assets
0%
Liabilities in 2025 (Year End)
$3,506,891
Grants Payable
>99%
Payables & Accruals
<1%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Other Liabilities
0%
Assets
2024
2025
Change
Cash & Equivalents
$1,728,967
$3,273,936
+89%
Receivables (Non-Related)
$98,325
$162,208
+65%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$30,653
$98,517
+221%
Investments
$13,184,925
$12,198,367
-7%
Property, Plant, & Equipment (net)
-
-
-
Other Assets
-
-
-
Total Assets
$15,042,870
$15,733,028
+5%
Liabilities
2024
2025
Change
Payables & Accruals
$31,650
$32,587
+3%
Grants Payable
$887,465
$3,474,304
+291%
Deferred Revenue
-
-
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
-
-
-
Total Liabilities
$919,115
$3,506,891
+282%
Net assets
2024
2025
Change
Restricted Net Assets
$2,080,785
$0
-100%
Unrestricted Net Assets
$12,042,970
$12,226,137
+2%
Net assets
2024
2025
Change
Net assets
+$14,123,755
+$12,226,137
-13%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)